Keeping a wary eye on Covid trends in South America. The good: cases/deaths there have come down from devastating peaks a few months back, and there’s progress on vaccinations. The bad: Delta may have only begun to circulate, and questions about vaccine efficacy
Most countries in the region have fully vaccinated between 20 and 40% of their populations; Chile and Uruguay stand out, with >70% fully vaccinated. Countries use a mix of vaccines, mostly Chinese inactivated vaccines (Sinovac and Sinopharm), plus some Pfizer & AstraZeneca
Chinese vaccines have lower effectiveness vs symptomatic disease but protect vs hospitalizations and death.
Chile estimated the Sinovac VE vs. symptomatic Covid at 58%, and 86% vs hospitalization. For Pfizer: 88% and 97%, AZ: 68% and 100%, respectively
minsal.cl/wp-content/upl…
Genomic sequencing data is fairly limited, but appears Gamma, Beta, Lambda have been responsible for much of the disease transmission in the region this year. Still, some signs Delta may be nosing its way in.
Data from covariants.org shows the proportions of different variants sequenced in countries over time. The Delta proportion (in green) has expanded quickly in Brazil & Argentina, and less common but increasing in Chile and Ecuador (again, limited data).
In almost every place Delta has taken root it has come to dominate transmission, due to its innate advantage of higher transmissibility. Could South America be looking at a Delta surge in the next weeks/months?
Also, will the effectiveness of Chinese vaccines, which make up the bulk of many countries’ vaccinations in the region, be compromised further because of Delta?

Data on these vaccines vs Delta hard to come by but a new *pre-print* raises concerns.
researchsquare.com/article/rs-828…
Authors reviewed outcomes in vaccinated vs unvaccinated, comparing across different vaccines in Bahrain, finding "a higher risk of COVID-19 infection and clinical escalation among recipients of the Sinopharm vaccine compared to other vaccine recipients” (especially in those >50)
So, a concern in South America that Delta spread creates another surge, and many people could be still be vulnerable despite fairly high vaccination coverage. For this reason, some governments have already moved to 3rd dose boosters for those who received Chinese vaccines.
Uruguay, for example, is asking that everyone in the country who received 2 doses of Sinovac receive a 3rd dose (of Pfizer). Chile has also started with booster shots for Sinovac recipients.
gub.uy/ministerio-sal…
Still, not all countries in the region are ready and able to provide 3rd doses, and are still struggling to get increase vaccine coverage for the first two doses.

Will be continuing to watch the situation

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Josh Michaud

Josh Michaud Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @joshmich

23 Aug
Some initial thoughts on full FDA approval of the Pfizer vaccine and what it might mean for vaccine acceptance in the US, based on @KFF polling and policy work
A commonly referenced finding from KFF's vaccine monitor is that 3 in 10 unvaccinated people reported they'd be more likely to get the vaccine upon full FDA approval
kff.org/coronavirus-co…
Still, I don't think it means that if unvaccinated people hear the news about full FDA approval 3 in 10 of will all of a sudden decide to get the shot based on that alone.
Read 8 tweets
21 May
G20 summit today featured many pledges, promises and proposals to address global gaps in COVID19 vaccine access. We'll have to see how many of these become concrete actions in the weeks and months ahead.
reuters.com/world/g20-heal…
Pfizer promised to provide 2 billion doses "at cost" for lower income countries over the next 18 months: 1 billion by the end of this year and another billion by the middle of 2022.
reuters.com/business/healt…
.@gavi and J&J announced a purchase agreement of 200 million doses of the J&J vaccine for distribution through COVAX this year
gavi.org/news/media-roo…
Read 6 tweets
15 Apr
Important data on "breakthrough" infections: CDC says 5,800 infections documented so far in the US, of which 396 (7%) needed to be hospitalized. About 77 million people have been fully vaccinated in the US.
cnn.com/2021/04/14/hea…
CDC says a "little over 40% of the infections were in people 60 or more years of age" but hard to draw too many conclusions from that given that the preponderance of the vaccinated are in that age group, too.
We knew these infections would occur, and that some could lead to severe disease and even death. In this article alone, three different experts used the phrase "not surprising" to describe the phenomenon. Vaccines are not 100% protective.
washingtonpost.com/health/2021/04…
Read 8 tweets
13 Apr
In light of J&J news, of primary concern with regard to vaccine confidence in the US is the 15-20% of adults still on the fence about getting vaccinated. Could the pause, and the messaging around it, change minds from "wait and see" to "no thanks"?
kff.org/coronavirus-co… Image
The most common concerns about vaccines in the "wait and see" group revolve around safety and side effects, so if a perception takes hold - for whatever reason - that a vaccine is "unsafe" it could have implications for willingness to be vaccinated especially in this group. Image
Can't predict how things will play out here, but concerning precedent that several European countries saw a decline in confidence in the AstraZeneca vaccine after a week-long pause initiated for similar reasons as we're seeing for J&J
dw.com/en/european-tr…
Read 6 tweets
19 Jan
30% of Israel's population has received at least 1 dose of Covid-19 vaccine, but no indications yet that case numbers are coming down there (chart).

A few reasons why this might be:

1) Cases reported now were infected 7+ days ago, when vaccinations were lower Image
2) Less than 500,000 (out of ~2.7 M vaccinated) have so far received a 2nd dose. A single dose is "less effective than we hoped" in providing protection, according to Israeli health leaders.
theguardian.com/world/2021/jan…
3) Israel has vaccinated by age, starting with older persons, vaccinating to date:
80% of 70+
68% of 60-69
50% of 50-59
28% 40-49

Older ages are protected from severe disease, but younger ages typically contribute most to transmission
timesofisrael.com/israelis-aged-…
Read 6 tweets
9 Jan
Beyond the scientific and epidemiological reasons to doubt the lab escape theory of pandemic origin, let’s not forget that no US or allied intelligence has emerged with even a whiff of evidence that a lab was the origin by accident or intention.
To believe the lab escape theory you also have to believe the Chinese have mounted a successful, extended campaign to eliminate incriminating evidence and muzzle officials and scientists who knew or might have suspected it came from a lab.
It’s a pretty big secret to hold on to, especially for a sizeable group of people that includes an international network of scientists, other workers, and families -- many of whom are not exactly in the secrecy business.
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(